熱門資訊> 正文
Zentalis Pharmaceuticals提交2.5亿美元混合证券货架
2025-03-27 04:31
- Zentalis Pharmaceuticals (NASDAQ:ZNTL) filed a prospectus for the offer and sale of $250M mixed securities shelf.
- This preliminary prospectus is not an offer to sell.
- Filing.
More on Zentalis Pharmaceuticals
- Zentalis to cut 40% of workforce, focus on azenosertib
- Zentalis Pharmaceuticals and PureTech Health get Fast Track Designation from FDA for their cancer treatments
- Seeking Alpha’s Quant Rating on Zentalis Pharmaceuticals
- Historical earnings data for Zentalis Pharmaceuticals
- Financial information for Zentalis Pharmaceuticals
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
